What Investors Need to Know About Jazz Pharmaceuticals’ Planned Acquisition of GW Pharmaceuticals

In the first marijuana industry buyout of 2021, Jazz Pharmaceuticals (NASDAQ: JAZZ) agreed to pay a hefty $7.6 billion to acquire GW Pharmaceuticals (NASDAQ: GWPH), a developer of cannabis-based medications.Will their fortunes suddenly change if the U.S. fully legalizes cannabis?Read MoreMarketsMarkets Feed

¡Haz clic para votar esta entrada!
(Votos: 0 Promedio: 0)

Deja un comentario